Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ZUHAYR S HEMADY

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1275591257
CMS profile
238965
Location
QUINCY, MA

General Payments · PY2018–2021

$2,227.19

  • Reported across 75 records
  • CMS publication 2026-01-23

Latest program year · PY2021

$301.98

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2021 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $301.98 16

By paying entity

PY2021 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $996.81 32
PY2019 $756.57 18
PY2020 $171.83 9
PY2021 $301.98 16

Payment records · PY2021 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2021 201820192020 Record-level detail is published for PY2021; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $24.80 02/12/2021 Food and Beverage Undisputed 01/23/2026 829884641 CMS
AstraZeneca Pharmaceuticals LP $14.93 07/22/2021 Food and Beverage Undisputed 01/23/2026 829961637 CMS
AstraZeneca Pharmaceuticals LP $24.81 10/22/2021 Food and Beverage Undisputed 01/23/2026 829720133 CMS
AstraZeneca Pharmaceuticals LP $21.42 12/03/2021 Food and Beverage Undisputed 01/23/2026 829832803 CMS
AstraZeneca Pharmaceuticals LP $15.82 12/09/2021 Food and Beverage Undisputed 01/23/2026 830062539 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.44 08/26/2021 Food and Beverage Undisputed 01/23/2026 763665288 CMS
GlaxoSmithKline, LLC. $15.85 05/20/2021 Food and Beverage Undisputed 01/23/2026 803139115 CMS
GlaxoSmithKline, LLC. $19.62 05/25/2021 Food and Beverage Undisputed 01/23/2026 802771067 CMS
GlaxoSmithKline, LLC. $16.09 06/03/2021 Food and Beverage Undisputed 01/23/2026 802644097 CMS
GlaxoSmithKline, LLC. $13.20 07/16/2021 Food and Beverage Undisputed 01/23/2026 802815259 CMS
GlaxoSmithKline, LLC. $19.86 11/11/2021 Food and Beverage Undisputed 01/23/2026 802534385 CMS
GlaxoSmithKline, LLC. $12.85 12/16/2021 Food and Beverage Undisputed 01/23/2026 803069297 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.38 05/13/2021 Food and Beverage Undisputed 01/23/2026 819970529 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.84 06/10/2021 Food and Beverage Undisputed 01/23/2026 819970533 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.08 07/15/2021 Food and Beverage Undisputed 01/23/2026 819970537 CMS
Teva Pharmaceuticals USA, Inc. $37.99 03/25/2021 Food and Beverage Undisputed 01/23/2026 839658885 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.